Graig Suvannavejh
Stock Analyst at Mizuho Securities
(4.85)
# 398
Out of 5,022 analysts
870
Total ratings
48.8%
Success rate
20.8%
Average return
Main Sectors:
Stocks Rated by Graig Suvannavejh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMRX Immuneering | Reiterated: Buy | $12 | $4.07 | +194.84% | 41 | Oct 2, 2026 | |
| IMMX Immix Biopharma | Reiterated: Buy | $26 | $9.68 | +168.60% | 10 | Sep 30, 2026 | |
| HRMY Harmony Biosciences Holdings | Reiterated: Buy | $51 | $39.64 | +28.66% | 83 | Sep 25, 2026 | |
| LONA LeonaBio | Reiterated: Buy | $15 | $4.82 | +211.20% | 46 | Sep 23, 2026 | |
| ALKS Alkermes | Reiterated: Buy | $24 → $65 | $41.75 | +55.69% | 4 | Sep 22, 2026 | |
| INSM Insmed | Reiterated: Buy | $195 | $111.12 | +75.49% | 58 | Sep 22, 2026 | |
| CRBP Corbus Pharmaceuticals Holdings | Reiterated: Buy | $33 | $6.13 | +438.34% | 27 | Sep 14, 2026 | |
| AXSM Axsome Therapeutics | Reiterated: Buy | $316 | $179.25 | +76.29% | 159 | Sep 11, 2026 | |
| PVLA Palvella Therapeutics | Reiterated: Buy | $240 | $132.47 | +81.17% | 10 | Sep 10, 2026 | |
| BLTE Belite Bio | Reiterated: Buy | $220 → $234 | $159.56 | +46.65% | 13 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $37.36 | +33.83% | 29 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $7.59 | +229.38% | 25 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $42 | $27.79 | +51.13% | 46 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 | $3.25 | +1,100.00% | 46 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.4999 | +700.16% | 26 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $10.90 | +175.23% | 23 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $73.00 | +36.99% | 15 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.52 | +217.46% | 2 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $13 | $7.70 | +68.83% | 36 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $35 | $29.71 | +17.81% | 32 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 | $1.81 | -17.13% | 39 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $5 | $14.74 | -66.08% | 7 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $1,500 → $75 | $0.385 | n/a | 3 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.037 | n/a | 12 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $0.7722 | n/a | 11 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 26.50 → CHF 17.00 | CHF 4.46 | n/a | 2 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €16.50 | €22.20 | n/a | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 → $50 | $109.86 | n/a | 4 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $6.5 | $1.78 | n/a | 2 | Nov 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €14.00 → €6.00 | €1.90 | n/a | 2 | Oct 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | €57.00 → €44.00 | €25.66 | n/a | 3 | Oct 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €14.00 → €14.50 | €2.53 | n/a | 2 | Sep 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $18 → $16 | $92.83 | n/a | 3 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $26 | $65.60 | n/a | 2 | Jul 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €4.00 → €3.50 | €1.32 | n/a | 2 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $135 → $96 | $94.45 | n/a | 5 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $28 | $12.34 | n/a | 1 | Apr 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $31 | $41.40 | n/a | 1 | Apr 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $64.51 | n/a | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 → $55 | $25.16 | n/a | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $7 | $10.55 | n/a | 2 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $99 → $90 | $29.37 | n/a | 2 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $4.75 | $1.55 | n/a | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $128 → $145 | $235.67 | n/a | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $37 | $3.67 | n/a | 1 | Oct 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $19 | $3.38 | n/a | 3 | May 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $60 | $322.28 | n/a | 1 | Sep 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $154 | $919.21 | n/a | 1 | Dec 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $54.29 | n/a | 2 | Sep 23, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10 → $11 | $3.80 | n/a | 5 | Jul 1, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2 → $1 | $0.0001 | n/a | 4 | May 28, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 | $3.45 | n/a | 1 | Apr 1, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 → $96 | $302.96 | n/a | 2 | Feb 13, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $4.49 | n/a | 2 | Feb 3, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $2 | $2.03 | n/a | 3 | Oct 15, 2013 |
Immuneering
Oct 2, 2026
Reiterated: Buy
Price Target: $12
Current: $4.07
Upside: +194.84%
Immix Biopharma
Sep 30, 2026
Reiterated: Buy
Price Target: $26
Current: $9.68
Upside: +168.60%
Harmony Biosciences Holdings
Sep 25, 2026
Reiterated: Buy
Price Target: $51
Current: $39.64
Upside: +28.66%
LeonaBio
Sep 23, 2026
Reiterated: Buy
Price Target: $15
Current: $4.82
Upside: +211.20%
Alkermes
Sep 22, 2026
Reiterated: Buy
Price Target: $24 → $65
Current: $41.75
Upside: +55.69%
Insmed
Sep 22, 2026
Reiterated: Buy
Price Target: $195
Current: $111.12
Upside: +75.49%
Corbus Pharmaceuticals Holdings
Sep 14, 2026
Reiterated: Buy
Price Target: $33
Current: $6.13
Upside: +438.34%
Axsome Therapeutics
Sep 11, 2026
Reiterated: Buy
Price Target: $316
Current: $179.25
Upside: +76.29%
Palvella Therapeutics
Sep 10, 2026
Reiterated: Buy
Price Target: $240
Current: $132.47
Upside: +81.17%
Belite Bio
Sep 9, 2026
Reiterated: Buy
Price Target: $220 → $234
Current: $159.56
Upside: +46.65%
Sep 1, 2026
Reiterated: Buy
Price Target: $50
Current: $37.36
Upside: +33.83%
Aug 20, 2026
Reiterated: Buy
Price Target: $25
Current: $7.59
Upside: +229.38%
Aug 19, 2026
Reiterated: Buy
Price Target: $24 → $42
Current: $27.79
Upside: +51.13%
Aug 17, 2026
Reiterated: Buy
Price Target: $39
Current: $3.25
Upside: +1,100.00%
Aug 17, 2026
Reiterated: Buy
Price Target: $4
Current: $0.4999
Upside: +700.16%
Aug 11, 2026
Reiterated: Buy
Price Target: $30
Current: $10.90
Upside: +175.23%
Aug 11, 2026
Reiterated: Buy
Price Target: $100
Current: $73.00
Upside: +36.99%
Aug 11, 2026
Reiterated: Buy
Price Target: $8
Current: $2.52
Upside: +217.46%
Aug 10, 2026
Reiterated: Buy
Price Target: $14 → $13
Current: $7.70
Upside: +68.83%
Aug 7, 2026
Reiterated: Hold
Price Target: $35
Current: $29.71
Upside: +17.81%
Jul 9, 2026
Reiterated: Hold
Price Target: $1.5
Current: $1.81
Upside: -17.13%
Dec 9, 2025
Reiterated: Buy
Price Target: $4 → $5
Current: $14.74
Upside: -66.08%
Oct 2, 2025
Downgraded: Hold
Price Target: $1,500 → $75
Current: $0.385
Upside: n/a
Aug 26, 2025
Rated: Hold
Price Target: n/a
Current: $0.037
Upside: n/a
Dec 14, 2023
Reiterated: Hold
Price Target: $1
Current: $0.7722
Upside: n/a
May 5, 2022
Reiterated: Hold
Price Target: CHF 26.50 → CHF 17.00
Current: CHF 4.46
Upside: n/a
May 5, 2022
Reiterated: Hold
Price Target: €16.50
Current: €22.20
Upside: n/a
Nov 15, 2021
Reiterated: Buy
Price Target: $55 → $50
Current: $109.86
Upside: n/a
Nov 9, 2021
Reiterated: Hold
Price Target: $13 → $6.5
Current: $1.78
Upside: n/a
Oct 28, 2021
Reiterated: Buy
Price Target: €14.00 → €6.00
Current: €1.90
Upside: n/a
Oct 5, 2021
Reiterated: Sell
Price Target: €57.00 → €44.00
Current: €25.66
Upside: n/a
Sep 21, 2021
Reiterated: Buy
Price Target: €14.00 → €14.50
Current: €2.53
Upside: n/a
Aug 4, 2021
Reiterated: Sell
Price Target: $18 → $16
Current: $92.83
Upside: n/a
Jul 20, 2021
Reiterated: Hold
Price Target: $16 → $26
Current: $65.60
Upside: n/a
Jun 29, 2021
Reiterated: Hold
Price Target: €4.00 → €3.50
Current: €1.32
Upside: n/a
May 14, 2021
Reiterated: Hold
Price Target: $135 → $96
Current: $94.45
Upside: n/a
Apr 20, 2021
Initiated Coverage: Hold
Price Target: $28
Current: $12.34
Upside: n/a
Apr 19, 2021
Initiated Coverage: Hold
Price Target: $31
Current: $41.40
Upside: n/a
Mar 2, 2021
Initiated Coverage: Buy
Price Target: $20
Current: $64.51
Upside: n/a
Feb 3, 2021
Reiterated: Buy
Price Target: $36 → $55
Current: $25.16
Upside: n/a
Jan 15, 2021
Reiterated: Buy
Price Target: $28 → $7
Current: $10.55
Upside: n/a
Dec 21, 2020
Reiterated: Sell
Price Target: $99 → $90
Current: $29.37
Upside: n/a
Nov 23, 2020
Initiated Coverage: Hold
Price Target: $4.75
Current: $1.55
Upside: n/a
Nov 11, 2020
Reiterated: Sell
Price Target: $128 → $145
Current: $235.67
Upside: n/a
Oct 20, 2020
Initiated Coverage: Hold
Price Target: $37
Current: $3.67
Upside: n/a
May 11, 2020
Reiterated: Buy
Price Target: $14 → $19
Current: $3.38
Upside: n/a
Sep 24, 2019
Initiated Coverage: Hold
Price Target: $60
Current: $322.28
Upside: n/a
Dec 17, 2018
Initiated Coverage: Buy
Price Target: $154
Current: $919.21
Upside: n/a
Sep 23, 2014
Initiated Coverage: Buy
Price Target: $16
Current: $54.29
Upside: n/a
Jul 1, 2014
Downgraded: Hold
Price Target: $10 → $11
Current: $3.80
Upside: n/a
May 28, 2014
Downgraded: Hold
Price Target: $2 → $1
Current: $0.0001
Upside: n/a
Apr 1, 2014
Downgraded: Hold
Price Target: $3
Current: $3.45
Upside: n/a
Feb 13, 2014
Reiterated: Buy
Price Target: $62 → $96
Current: $302.96
Upside: n/a
Feb 3, 2014
Reiterated: Buy
Price Target: $27
Current: $4.49
Upside: n/a
Oct 15, 2013
Downgraded: Hold
Price Target: $15 → $2
Current: $2.03
Upside: n/a